Epidemiology of hip fracture in Iraq and development of a country-specific FRAX model
- PMID: 41296216
- PMCID: PMC12657562
- DOI: 10.1007/s11657-025-01631-3
Epidemiology of hip fracture in Iraq and development of a country-specific FRAX model
Abstract
Hip fracture data were retrieved from the Iraqi government's Ministry of Health and the Kurdistan region's Ministry of Health for the years 2022-2023 and used to create a FRAX® model to facilitate fracture risk assessment. Hip fracture rates and probabilities were compared with estimates from neighboring countries.
Introduction: There are no published data on the epidemiology of osteoporotic fractures in Iraq. This paper describes the epidemiology of femoral fractures in Iraq and the development of the corresponding country-specific FRAX® tool for the prediction of fractures.
Methods: Femoral fracture data (ICD-10 S72) were retrieved from the Iraqi government's Ministry of Health and the Kurdistan region's Ministry of Health for the years 2022-2023 in Iraq. The age- and sex-specific incidence of hip fracture in Iraqi residents and national mortality rates were used to create a FRAX® model. Fracture probabilities were compared with those from neighboring countries having existing FRAX models.
Results: Fracture rates were low and comparable to those in neighboring countries, with hip fracture rates closest to estimates from Saudi Arabia at older ages. Ten-year fracture probabilities were lower in males than in females and were comparable to those in neighboring countries.
Conclusion: The FRAX model should enhance the accuracy of determining fracture probability among the Iraqi population and help guide treatment decisions.
Keywords: Epidemiology; FRAX; Fracture probability; Hip fracture; Iraq.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval: Only summary statistics and aggregate data are published, not allowing for the identification of individual study participants. Human and animal rights: This study does not contain any original studies with human participants or animals performed by any of the authors. Competing interests: Ahmed Abdulbari, Nizar A.Jassim, Yasir H.Motlaq, Hassan A. Ismael, Waleed Arif Tawfeeq Al Ani, Chra Kawa M.Nafai, Ali Abdulrahman Younis, Taha Ahmed Qaradaghi, Farah Jaafar Mahdi, Abbas Mahdi Rahmah, Alaa Hussein Alameri, Fareed Alsudany, Zaid W Al-Shahwani, Tariq Jassim Mohammed, Mohannad Khalil Ahmed Abu Khumrah, Adra Abdul Ruda Kadum, Asal Adnan, Marwan Z Yahya, Nicholas C Harvey, Mattias Lorentzon, and Helena Johansson declare that they have no conflict of interest concerning this paper. E McCloskey and JA Kanis are directors of Osteoporosis Research Ltd, which maintains FRAX.
Figures
References
-
- Kanis JA, Harvey NC, Cooper C, Johansson H, Odén A, McCloskey EV, the Advisory Board of the National Osteoporosis Guideline Group (2016) A systematic review of intervention thresholds based on FRAX. A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11:25. 10.1007/s11657-016-0278-z - DOI - PMC - PubMed
-
- Kanis JA on behalf of the World Health Organization Scientific Group (2007). Assessment of osteoporosis at the primary healthcare level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK. Available at https://frax.shef.ac.uk/FRAX/reference.aspx. Accessed 9 July 2025
-
- Willers C, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, McCloskey EV, Borgström F, Kanis JA; SCOPE review panel of the IOF (2022) Osteoporosis in Europe: a compendium of country-specific reports. Arch Osteoporos 17(1):23. 10.1007/s11657-021-00969-8
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
